Long-term Survival and Influencing Factors of Patients With Pulmonary Arterial Hypertension and Diabetes

N/ANot Yet RecruitingNCT07082933

Xijing Hospital5,000 enrolled

Overview

This is a multicenter retrospective cohort study on pulmonary arterial hypertension. It is expected to collect data from no less than 5,000 patients to compare the long-term overall survival of patients with and without diabetes, and analysis the risk factors of the overall survival .

Study Type

OBSERVATIONAL

Enrollment

5,000

Conditions

Pulmonary Arterial Hypertension (PAH)

Interventions

Standard medical treatmentOTHER

Standard medical treatment

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Individuals aged 18 to 80 years with full capacity for civil conduct. * Patients diagnosed with pulmonary hypertension by community-level and/or higher-level medical institutions. Exclusion Criteria: * Patients with malignant tumors. * Other physical conditions judged by the researchers as making the patients ineligible to participate in the clinical study.

Outcomes

Primary Outcomes

Overall Survival

Time from diagnosis of pulmonary hypertension to death

Time frame: 10 years

Secondary Outcomes

Pulmonary Artery Pressure(PAP)

Time frame: baseline

Central Contacts

Yue Zhang, Doctor

CONTACT

0086+13022957751 zhangy718@foxmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.